120 related articles for article (PubMed ID: 10047775)
21. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer.
Rass K; Reichrath J
Adv Exp Med Biol; 2008; 624():162-78. PubMed ID: 18348455
[TBL] [Abstract][Full Text] [Related]
22. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
Stern RS;
J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
[TBL] [Abstract][Full Text] [Related]
23. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma.
Wei Q; Lee JE; Gershenwald JE; Ross MI; Mansfield PF; Strom SS; Wang LE; Guo Z; Qiao Y; Amos CI; Spitz MR; Duvic M
J Natl Cancer Inst; 2003 Feb; 95(4):308-15. PubMed ID: 12591987
[TBL] [Abstract][Full Text] [Related]
24. p53 codon 72 polymorphism, DNA damage and repair, and risk of non-melanoma skin cancer.
Bendesky A; Rosales A; Salazar AM; Sordo M; Peniche J; Ostrosky-Wegman P
Mutat Res; 2007 Jun; 619(1-2):38-44. PubMed ID: 17403527
[TBL] [Abstract][Full Text] [Related]
25. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
Maier H; Schemper M; Ortel B; Binder M; Tanew A; Hönigsmann H
Dermatology; 1996; 193(3):185-91. PubMed ID: 8944338
[TBL] [Abstract][Full Text] [Related]
26. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
Stern RS; Laird N
Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
[TBL] [Abstract][Full Text] [Related]
27. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
28. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
Lim JL; Stern RS
J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
[TBL] [Abstract][Full Text] [Related]
29. Psoriasis and susceptibility to nonmelanoma skin cancer.
Stern RS; Scotto J; Fears TR
J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):67-73. PubMed ID: 3980806
[TBL] [Abstract][Full Text] [Related]
30. A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma.
Wang L; Wei Q; Shi Q; Guo Z; Qiao Y; Spitz MR
Carcinogenesis; 2007 Jul; 28(7):1430-6. PubMed ID: 17341660
[TBL] [Abstract][Full Text] [Related]
31. Association study of genetic variation in DNA repair pathway genes and risk of basal cell carcinoma.
Lin Y; Chahal HS; Wu W; Cho HG; Ransohoff KJ; Song F; Tang JY; Sarin KY; Han J
Int J Cancer; 2017 Sep; 141(5):952-957. PubMed ID: 28510302
[TBL] [Abstract][Full Text] [Related]
32. No association between the DNA repair gene XRCC3 T241M polymorphism and risk of skin cancer and breast cancer.
Jacobsen NR; Nexø BA; Olsen A; Overvad K; Wallin H; Tjønneland A; Vogel U
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):584-5. PubMed ID: 12815008
[No Abstract] [Full Text] [Related]
33. DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma.
Landi MT; Baccarelli A; Tarone RE; Pesatori A; Tucker MA; Hedayati M; Grossman L
J Natl Cancer Inst; 2002 Jan; 94(2):94-101. PubMed ID: 11792747
[TBL] [Abstract][Full Text] [Related]
34. Human 8-oxoguanine-DNA glycosylase-1 is downregulated in human basal cell carcinoma.
Huang XX; Scolyer RA; Abubakar A; Halliday GM
Mol Genet Metab; 2012 May; 106(1):127-30. PubMed ID: 22436579
[TBL] [Abstract][Full Text] [Related]
35. DNA repair and nonmelanoma skin cancer in Puerto Rican populations.
Matta JL; Villa JL; Ramos JM; Sanchez J; Chompré G; Ruiz A; Grossman L
J Am Acad Dermatol; 2003 Sep; 49(3):433-9. PubMed ID: 12963906
[TBL] [Abstract][Full Text] [Related]
36. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin.
Thirumaran RK; Bermejo JL; Rudnai P; Gurzau E; Koppova K; Goessler W; Vahter M; Leonardi GS; Clemens F; Fletcher T; Hemminki K; Kumar R
Carcinogenesis; 2006 Aug; 27(8):1676-81. PubMed ID: 16501254
[TBL] [Abstract][Full Text] [Related]
37. Frequent basal cell cancer development is a clinical marker for inherited cancer susceptibility.
Cho HG; Kuo KY; Li S; Bailey I; Aasi S; Chang ALS; Oro AE; Tang JY; Sarin KY
JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089731
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms in nucleotide excision repair genes and basal cell carcinoma of the skin.
Pesz KA; Bieniek A; Gil J; Laczmanska I; Karpinski P; Makowska I; Trusewicz A; Sasiadek MM
Int J Dermatol; 2014 Dec; 53(12):1474-7. PubMed ID: 25209577
[TBL] [Abstract][Full Text] [Related]
39. Reduced DNA repair capacity in lung cancer patients.
Wei Q; Cheng L; Hong WK; Spitz MR
Cancer Res; 1996 Sep; 56(18):4103-7. PubMed ID: 8797573
[TBL] [Abstract][Full Text] [Related]
40. Pre-diagnostic leukocyte mitochondrial DNA copy number and skin cancer risk.
Meng S; De Vivo I; Liang L; Giovannucci E; Tang JY; Han J
Carcinogenesis; 2016 Sep; 37(9):897-903. PubMed ID: 27381830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
